Reuters -- Quest Diagnostics Inc (DGX.N), the No. 1 U.S. provider of medical testing services, posted a 7 percent rise in quarterly profit, helped by cost controls and increased demand for specialized tests such as for cancer.
Reuters -- Quest Diagnostics Inc (DGX.N), the No. 1 U.S. provider of medical testing services, posted a 7 percent rise in quarterly profit, helped by cost controls and increased demand for specialized tests such as for cancer.
